Upstate Active Clinical Trials
Study Title:Prospective Validation of Prostate Biomarkers for Repeat Biopsy:The PRIORITY Study
What is the purpose of the study?This study is being conducted to evaluate the performance of the ConfirmMDx and SelectMDx tests for Prostate Cancer to identify patients with increased risk for clinically significant disease, and to lower the rate of repeat biopsies.
Upstate Institutional Review Board (IRB) Number:1022360
Study/Protocol ID:The PRIORITY Study
Patient Age Group:Adults
Principal Investigator:Gennady Bratslavsky, MD
Who can I contact for more information?
Name: Nicholas Carusone, BS